Researchers demonstrated that apigenin arrests prostate cancer cells at G2 phase by flow cytometric analysis of prostate cancer cells co-stained for phospho-Histone H3 and DNA.
[Discover Oncology]
Apigenin Impedes Cell Cycle Progression at G2 Phase in Prostate Cancer Cells
